4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene

C30H28N6 — CID 134269739

IUPAC4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene
SMILESCC(C)c1nc2c([nH]1)CCc1cc(-c3ccc4c(c3)c3nccnc3c3[nH]c(C(C)C)nc43)ccc1-2
InChIInChI=1S/C30H28N6/c1-15(2)29-33-23-10-7-19-13-17(5-8-20(19)24(23)34-29)18-6-9-21-22(14-18)25-27(32-12-11-31-25)28-26(21)35-30(36-28)16(3)4/h5-6,8-9,11-16H,7,10H2,1-4H3,(H,33,34)(H,35,36)
InChIKeyOIKYWYGNHNFIOT-UHFFFAOYSA-N
MW472.60 g/mol
LogP7.06
Rot. Bonds3

About 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene

4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene (PubChem CID 134269739) has the molecular formula C30H28N6 and a molecular weight of 472.60 g/mol. Its IUPAC name is 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene.

Molecular Properties

Compound Name4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene
PubChem CID134269739
Molecular FormulaC30H28N6
Molecular Weight472.60 g/mol
Exact Mass472.24
IUPAC Name4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene
SMILESCC(C)c1nc2c([nH]1)CCc1cc(-c3ccc4c(c3)c3nccnc3c3[nH]c(C(C)C)nc43)ccc1-2
InChIInChI=1S/C30H28N6/c1-15(2)29-33-23-10-7-19-13-17(5-8-20(19)24(23)34-29)18-6-9-21-22(14-18)25-27(32-12-11-31-25)28-26(21)35-30(36-28)16(3)4/h5-6,8-9,11-16H,7,10H2,1-4H3,(H,33,34)(H,35,36)
InChIKeyOIKYWYGNHNFIOT-UHFFFAOYSA-N
XLogP7.06
TPSA83.14 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500472.60
LogP ≤ 57.06
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene?
The IUPAC name of 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene (CID 134269739) is 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene.
What is the SMILES notation for 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene?
The canonical SMILES for 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene is CC(C)c1nc2c([nH]1)CCc1cc(-c3ccc4c(c3)c3nccnc3c3[nH]c(C(C)C)nc43)ccc1-2.
What is the InChIKey of 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene?
The InChIKey is OIKYWYGNHNFIOT-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H28N6/c1-15(2)29-33-23-10-7-19-13-17(5-8-20(19)24(23)34-29)18-6-9-21-22(14-18)25-27(32-12-11-31-25)28-26(21)35-30(36-28)16(3)4/h5-6,8-9,11-16H,7,10H2,1-4H3,(H,33,34)(H,35,36).
What are the key properties of 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene?
4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene has a molecular weight of 472.60 g/mol, XLogP of 7.06, 3 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-propan-2-yl-15-(2-propan-2-yl-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl)-3,5,8,11-tetrazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),3,7,9,11,14,16-octaene is sourced from PubChem (CID 134269739), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).